Fuminori Sugihara Selected Research

Fuminori Sugihara Research Topics

Disease

10	COVID-19 12/2023 - 01/2021
5	Inflammation (Inflammations) 12/2023 - 01/2016
4	Sepsis (Septicemia) 01/2023 - 01/2021
3	Fibrosis (Cirrhosis) 12/2023 - 01/2017
2	Infections 12/2023 - 10/2021
2	Critical Illness (Critically Ill) 10/2023 - 09/2022
2	Neoplasms (Cancer) 03/2015 - 01/2015
2	Polyps 02/2007 - 04/2006
1	Dyspnea (Shortness of Breath) 12/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2023
1	Parasitic Diseases (Parasitic Disease) 11/2023
1	Thrombosis (Thrombus) 10/2023
1	Burns 08/2023
1	Arthritis (Polyarthritis) 01/2023
1	Peritonitis 01/2023
1	Gouty Arthritis 01/2023
1	Disease Progression 09/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Multiple Sclerosis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022
1	Emphysema 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Osteoporosis 01/2021
1	Paralysis (Palsy) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Whooping Cough (Pertussis) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2015
1	Mental Disorders (Mental Disorder) 09/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 12/2023 - 01/2017
2	RNA (Ribonucleic Acid)IBA 11/2023 - 11/2022
2	Messenger RNA (mRNA)IBA 11/2022 - 09/2022
2	Blood Proteins (Serum Proteins)IBA 09/2022 - 01/2021
2	CytokinesIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
2	PolyphosphatesIBA 02/2007 - 04/2006
1	Interleukin-33IBA 12/2023
1	CollagenIBA 12/2023
1	AntibodiesIBA 12/2023
1	EpitopesIBA 12/2023
1	Blocking AntibodiesIBA 12/2023
1	Immunoglobulin FragmentsIBA 12/2023
1	GTP Phosphohydrolases (GTPases)IBA 11/2023
1	ProlactinIBA 11/2023
1	Toll-Like Receptor 3IBA 11/2023
1	Complement Factor B (Factor B)IBA 10/2023
1	Complement Factor D (Factor D)IBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	ProteomeIBA 10/2023
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2023
1	Tocopherols (Tocopherol)IBA 01/2023
1	aluminum sulfate (alum)IBA 01/2023
1	AerosolsIBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 09/2022
1	InterferonsIBA 09/2022
1	Interleukin-27 (Interleukin 27)IBA 09/2022
1	Interferon Type IIBA 01/2022
1	ResistinIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021
1	Melanins (Melanin)IBA 10/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Sirtuin 1IBA 01/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	SmokeIBA 01/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	Parathyroid Hormone (Parathormone)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	ChemokinesIBA 01/2020
1	2,6-dinitrotoluene (DNT)IBA 01/2020
1	Pertussis ToxinIBA 01/2020
1	Adenylate Cyclase ToxinIBA 01/2020
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2017
1	CEACAM1 ProteinIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Drug CarriersIBA 03/2015
1	Phosphorylcholine (Phosphocholine)IBA 01/2015
1	PolymersIBA 01/2015
1	Monoamine Oxidase (MAO)IBA 09/2011
1	Adenosine Triphosphate (ATP)IBA 02/2007

Therapy/Procedure

3	Therapeutics 11/2023 - 03/2015
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021